Beta Bionics (BBNX) FCF Margin (2024 - 2026)

Beta Bionics has disclosed FCF Margin across 3 years of filings, most recently posting 91.25% for Q1 2026.

• FCF Margin for Q1 2026 came in at 91.25%, up 2388.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 55.45% (up 2965.0% YoY), and the FY2025 annual result was 56.08%, up 2326.0% from the prior year.
• FCF Margin came in at 91.25% for Q1 2026 at Beta Bionics, down from 43.23% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 31.8% in Q3 2025 to a low of 115.13% in Q1 2025.
• The 3-year median for FCF Margin is 72.6% (2024), against an average of 73.59%.
• Peak annual rise in FCF Margin reached 3699 bps in 2025, while the deepest fall reached 1809 bps in 2025.
• Beta Bionics' FCF Margin stood at 72.6% in 2024, then soared by 40 bps to 43.23% in 2025, then slumped by 111 bps to 91.25% in 2026.
• The last three FCF Margin figures came in at 91.25% (Q1 2026), 43.23% (Q4 2025), and 31.8% (Q3 2025), per Business Quant data.